Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion type Assertion NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_head.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_provenance.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion evidence source_evidence_literature NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_provenance.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion SIO_000772 22197930 NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_provenance.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion wasDerivedFrom befree-20140225 NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_provenance.
- NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_assertion wasGeneratedBy ECO_0000203 NP808160.RAYqyH-Yvh7e7KOEhHdBlr7RXYq36V6gGgxr21rRPpYEk130_provenance.